Key Takeaways
- • The EU raised roughly US $39.1 billion in venture capital in 2025 versus US $283.3 billion in the United States, according to Dealroom data cited in the article.
- • The gap is concentrated after the seed stage: EU early- and growth-stage VC totaled about US $28 billion in 2025 against US $115 billion in the US, while pre-seed and seed investment was roughly US $3 billion in the EU and US $2.7 billion in the US.
- • Domestic capital is a key differentiator: 76% of US early-stage VC comes from domestic investors versus 55% in Europe, and just 30% of European late-stage VC is domestic compared with 81% in the US.
- • Dry powder gap: US VC firms held US $307 billion in uninvested capital in 2024 versus US $62 billion in Europe, roughly US $887 per American against US $138 per European.
- • The authors identify six supply-side constraints in two categories: structural (pension architecture, lack of endowments and foundations, bank-dominated finance) and disincentive (regulatory capital charges under Solvency II and Basel III, capital market fragmentation, weak exit environment).
Summary
The funding gap is most visible after seed stage. Citing Dealroom (2025), the article reports that US VC transactions reached US $405.4 billion in 2021, more than five times the US $72.8 billion invested in the EU, and that by 2025 US investment had recovered to US $283.3 billion while the EU stagnated at US $39.1 billion. Pre-seed and seed investment in the EU, roughly US $3 billion, was slightly above US levels of US $2.7 billion, but early- and growth-stage rounds showed the US at US $115 billion against US $28 billion in the EU. The authors describe this as the "Valley of Death" in which firms exhaust R&D funding before reaching profitability.
The article attributes the shortfall to six supply-side constraints. Structural constraints include the role of pay-as-you-go pension systems in Europe, where pension funds supply 7.6% of VC funding compared with 30.7% in the US; the near absence of endowments and foundations, at 5.5% in the EU versus 27.8% in the US; and a bank-dominated financial system in which financial intermediaries provide 41.3% of EU VC funding against 10.8% in the US. Disincentive constraints include regulatory capital charges under Solvency II and Basel III, which the authors say reserve capital against VC holdings for insurers and banks despite serving legitimate financial-stability objectives; tax and legal fragmentation across member states; and a weak exit environment with limited IPO and acquisition opportunities. The article states that existing EU policy responses are steps in the right direction but insufficient, and it sets out policy recommendations to address the gap.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.